Results 141 to 150 of about 1,950 (155)

Efficacy and Safety of Roxadustat in Chinese Hemodialysis Patients: A Systematic Review and Meta-Analysis

Journal of Clinical Medicine, 2023
(1) Background: Recently more and more Chinese clinical studies have been conducted to compare the efficacy and safety of roxadustat with erythropoiesis-stimulating agents (ESAs) in hemodialysis (HD) patients.
Huiping Zhao, Li Zuo, Qichen Liang
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patients

Therapeutic Apheresis and Dialysis, 2021
Tadao Akizawa, Michael Reusch, Yoshikatsu Majikawa   +2 more
exaly  

A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study

Kidney International Reports, 2021
Robert Leong, Gopal Saha, Lynda Szczech
exaly  

People also looked at

Frontiers in Pharmacology, 2022
Xiaoyu Zhu, Yujun Du, Mengtuan Long
exaly  

Roxadustat (FG-4592) treatment for anemia in dialysis-dependent (DD) and not dialysis-dependent (NDD) chronic kidney disease patients: A systematic review and meta‐analysis

Pharmacological Research, 2020
Jamal Rahmani, Akshaya S. Bhagavathula, Giulia Rinaldi   +2 more
exaly  

Roxadustat induces hepatotoxicity in zebrafish embryos via inhibiting Notch signaling

Journal of Applied Toxicology, 2023
Zigang Cao, Xinjun Liao, Mengqi Wan
exaly  

Effect of Roxadustat on Thyroid Function in Patients With Renal Anemia

Journal of Clinical Endocrinology and Metabolism, 2023
Yoshiyuki Hamamoto, Daisuke Yabe, Yuichiro Yamada   +2 more
exaly  

People also looked at

Frontiers in Medicine, 2021
Yuichirou Ueda, Kiyonori Ito, Yoshiyuki Morishita   +2 more
exaly  

Roxadustat attenuates experimental pulmonary fibrosis and

Toxicology Letters, 2020
Hongbo Wang, Xue Zhang, Haidi Huang
exaly  

Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo-Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients

Journal of Clinical Pharmacology, 2020
James J Chou, Thomas B Neff, Robert Provenzano   +2 more
exaly